Intelligent Bio Solutions Balance Sheet Health
Financial Health criteria checks 4/6
Intelligent Bio Solutions has a total shareholder equity of $5.9M and total debt of $499.6K, which brings its debt-to-equity ratio to 8.4%. Its total assets and total liabilities are $11.7M and $5.8M respectively.
Key information
8.4%
Debt to equity ratio
US$499.61k
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.99m |
| Equity | US$5.95m |
| Total liabilities | US$5.78m |
| Total assets | US$11.73m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: INBS's short term assets ($6.5M) exceed its short term liabilities ($5.7M).
Long Term Liabilities: INBS's short term assets ($6.5M) exceed its long term liabilities ($97.8K).
Debt to Equity History and Analysis
Debt Level: INBS has more cash than its total debt.
Reducing Debt: INBS had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: INBS has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: INBS has less than a year of cash runway if free cash flow continues to reduce at historical rates of 12.9% each year